Spero Therap
SPRO1.1800.84% ( -0.010 )
Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Overview: Spero Therap(SPRO) the Revenue is 258 K (-95.61%);the EBIT is -7.538 M (+48.21%);the EPS is -0.126 (+49.78%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.00B95.61%
----
----
EBIT
-0.01B48.21%
----
----
EPS
-0.125749.78%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf